Maxime Dely: The Vital Role of Plasma-Derived Clotting Factors in Rare Disease Care
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, has shared a post on LinkedIn:
”Clotting factors: when plasma becomes a life-saving medicine
Plasma-derived medicinal products (PDMPs), such as factor VIII or IX concentrates, remain essential for patients living with rare and severe bleeding disorders
Conditions treated:
- Hemophilia A and B (factor VIII or IX deficiency)
- Rare congenital deficiencies (factor V, XI, XIII, protein S, plasminogen…)
- Severe coagulation disorders linked to liver disease, trauma, or critical care situations
Across the world, millions of patients rely every year on plasma-derived medicines when recombinant alternatives are not yet available, effective, or well tolerated.
In many cases, these treatments are the only therapeutic option capable of preventing life-threatening bleeding and enabling a normal quality of life.
Behind every vial of medicine lies a plasma donation — transformed into treatment, hope, and survival for patients facing rare diseases.
How can we raise greater awareness of the vital role that plasma-derived coagulation factors play in rare disease care and innovation?”
Stay updated on the emerging in transfusion medicine with Hemostasis Today.
-
Sep 19, 2026, 10:34Nawsherwan Mohammad: ASH 2026 Guidelines Redefine How We Detect Iron Deficiency
-
Sep 19, 2026, 10:21Upcoming Podcast on Thalassaemia with The Lancet Haematology
-
Sep 19, 2026, 10:20Steve Helm: Cardiology and Anticoagulation Pharmacist Role Opens Near NYC
-
Sep 19, 2026, 10:12Omid Seidizadeh: A Great Pleasure to Speak on vWD at the 59th NordCoag Congress
-
Sep 19, 2026, 10:08Carsten Hansen: What Happens During a Sickle Cell Crisis?
-
Sep 19, 2026, 10:05Alan Nurden: Thyroid Hormones as Regulators of Acute Platelet Release
-
Sep 19, 2026, 10:02Oliver Weingärtner: What Can Real-World Data Teach Us about Long-Term Treatment Persistence in CP?
-
Sep 19, 2026, 09:55Ammar Alsughayir: When Transfusion Safety Becomes a Lifelong Commitment
-
Sep 19, 2026, 09:53Dilini Christina Ranasinghe: Exploring Red Cell Exchange in Sickle Cell Disease